FIP President Paul Sinclair AM MPS (left)[/caption]
‘Health care across the world is changing very quickly. It’s being driven by innovation, and pharmacists historically have embraced innovation and technology,' he said.
‘What excites me most about our profession at the moment is that we have the chance to do more. Our scope of practice is expanding rapidly, and with that comes opportunities to help more people deliver more outcomes and improve the health system.'
[post_title] => What are pharmacists doing in other countries?
[post_excerpt] => Pharmacists present to the International Pharmaceutical Federation (FIP) on unique services in their country to improve health and safety.
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => what-are-pharmacists-doing-in-other-countries
[to_ping] =>
[pinged] =>
[post_modified] => 2024-09-04 16:43:37
[post_modified_gmt] => 2024-09-04 06:43:37
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://www.australianpharmacist.com.au/?p=27474
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[title_attribute] => What are pharmacists doing in other countries?
[title] => What are pharmacists doing in other countries?
[href] => https://www.australianpharmacist.com.au/what-are-pharmacists-doing-in-other-countries/
[module_atts:td_module:private] => Array
(
)
[td_review:protected] => Array
(
)
[is_review:protected] =>
[post_thumb_id:protected] => 27493
[authorType] =>
)
Debbie Rigby FPS explaining how to correctly use different inhaler devices[/caption]
FIP award winner Dr Sarah Dineen-Griffin fourth from left[/caption]
Shania Liu received the Early Career in Pharmaceutical Practice Recognition Award. Presented every 3 years, the award recognises an educational program or innovation that promotes excellence in learning and teaching in any pharmacy discipline.
Dr Liu is the immediate past Chair of the Pain Management Leadership Committee of the Society of Hospital Pharmacists of Australia. Her research involved the improvement of the safe use of opioids before and after surgery.
Currently, she is a Postdoctoral Research Fellow in the Faculty of Medicine and Dentistry at the University of Alberta, Canada.
Sarah Dineen-Griffin was one of 10 new Fellows of FIP appointed at the Congress. FIP Fellowship recognises individual FIP members who have exhibited strong leadership internationally, distinguished themselves in pharmacy practice or the pharmaceutical sciences and who have contributed to the advancement of the practice of pharmacy or pharmaceutical sciences.
Dr Dineen-Griffin is a full-time teaching and research academic in the School of Biomedical Sciences and Pharmacy at the University of Newcastle. Currently she is Chief Investigator and Project Lead for the NSW/ACT Government Scope of Practice Pharmacy Trials. She is also the Vice President of the FIP Community Pharmacy Section.
[post_title] => FIP congress and two Australians honoured
[post_excerpt] => Find out what pharmacy topics are being discussed on the world stage at FIP, along with the Australians who received top honours.
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => fip-congress-and-two-australians-honoured
[to_ping] =>
[pinged] =>
[post_modified] => 2024-09-03 11:02:11
[post_modified_gmt] => 2024-09-03 01:02:11
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://www.australianpharmacist.com.au/?p=27411
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[title_attribute] => FIP congress and two Australians honoured
[title] => FIP congress and two Australians honoured
[href] => https://www.australianpharmacist.com.au/fip-congress-and-two-australians-honoured/
[module_atts:td_module:private] => Array
(
)
[td_review:protected] => Array
(
)
[is_review:protected] =>
[post_thumb_id:protected] => 27414
[authorType] =>
)
Queensland-based GP pharmacist Amy Gibson MPS[/caption]
References
- Khanna S, Shaw L, Hyman MJ, et al. Association of metformin use with risk of newly onset neovascular age-related macular degeneration development. Retina 2024;44(2):205–13.
- Macular Disease Foundation Australia. About age-related macular degeneration Sydney (NSW): Macular Disease Foundation Australia,; n.d. At: mdfoundation.com.au/about-macular-disease/age-related-macular-degeneration/amd-overview/
- National Eye Institute. Age-related macular degeneration (AMD) Bethesda (MD): National Eye Institute,; 2021. At: nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/age-related-macular-degeneration#:~:text=Age%2Drelated%20macular%20degeneration%20(AMD)%20is%20an%20eye%20disease,the%20back%20of%20the%20eye)
- Macular Disease Foundation Australia. Treatment for age-related macular degeneration Sydney (NSW): Macular Disease Foundation Australia,; n.d. At: mdfoundation.com.au/about-macular-disease/age-related-macular-degeneration/amd-treatment/#:~:text=Anti%2DVEGF%20medication%20can%20block,the%20vitreous)%20inside%20the%20eye
- Australian Medicines Handbook. Australian Medicines Handbook – Rifaximin: Australian Medicines Handbook Pty Ltd; 2023.
- Waldenlind K, Delcoigne B, Saevarsdottir S, et al. Disease-modifying antirheumatic drugs and risk of thyroxine-treated autoimmune thyroid disease in patients with rheumatoid arthritis. J Intern Med 2024;295(3):313–21.
